Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760721 · ClinicalTrials.gov registry record · Phase 3
Increasing Hepatitis B Screening Among Korean Church Attendees
A Phase 3 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,123
- Enrollment target
NCT00760721 is a Phase 3 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1,123 participants.
The verdict
NCT00760721, a Phase 3 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,123 participants
- Enrollment target
Study Summary
The purpose of this study is to design an intervention to increase hepatitis B (HBV) screening among Korean Americans. The investigators will design a culturally specific intervention (educational sessions) and test the effect of the intervention on 1200 Korean Americans. All subjects will be interviewed before the intervention/control sessions and 6 months after the sessions to assess HBV screening levels in the two groups. Self-reported HBV screening will be verified by a review of subjects' medical records. The primary study hypothesis is that the intervention group will have a higher rate of HBV serologic testing at follow-up compared to the control group.
Interventions
- BEHAVIORAL Educational Small Group Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,123 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00760721
The ClinicalTrials.gov registry entry for NCT00760721 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational Small Group Session is the first listed.
NCT00760721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00760721 about?
NCT00760721 is a clinical study titled "Increasing Hepatitis B Screening Among Korean Church Attendees". The purpose of this study is to design an intervention to increase hepatitis B (HBV) screening among Korean Americans. The investigators will design a culturally specific intervention (educational sessions) and test the effect of the intervention on 1200 Korean Americans. All subjects will be inte...
What is the current status of trial NCT00760721?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,123 participants. The study started on 2006-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00760721?
The interventions under investigation include: Educational Small Group Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT00760721?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.